Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,040 | -12,385 | -6,376 | -35,120 | -29,393 |
| Depreciation Amortization | 2,210 | 1,781 | 1,375 | 1,661 | 1,203 |
| Accounts receivable | -1,235 | -410 | -18 | -728 | -277 |
| Accounts payable and accrued liabilities | 831 | 404 | 199 | 1,335 | 725 |
| Other Working Capital | -952 | -1,959 | 746 | 1,406 | 904 |
| Other Operating Activity | 3,188 | 1,884 | 565 | 18,710 | 18,107 |
| Operating Cash Flow | $-15,999 | $-10,685 | $-3,509 | $-12,737 | $-8,731 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -23 | -23 | -66 | -69 |
| Purchase Sale Intangibles | -258 | -112 | -81 | -206 | -88 |
| Other Investing Activity | -258 | -237 | -81 | -206 | -88 |
| Investing Cash Flow | $-281 | $-260 | $-104 | $-273 | $-157 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 500 | 500 | 8,500 | 8,700 |
| Debt Repayment | -5,192 | -5,192 | -5,092 | -2,150 | -51 |
| Common Stock Issued | 78,991 | 48,519 | 45,431 | 8,087 | 316 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -50 |
| Financing Cash Flow | $74,299 | $43,827 | $40,839 | $14,437 | $8,916 |
| Beginning Cash Position | 1,554 | 1,554 | 1,554 | 126 | 126 |
| End Cash Position | 59,572 | 34,436 | 38,780 | 1,554 | 154 |
| Net Cash Flow | $58,019 | $32,882 | $37,226 | $1,427 | $28 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,999 | -10,685 | -3,509 | -12,737 | -8,731 |
| Capital Expenditure | -24 | -23 | -23 | -66 | -69 |
| Free Cash Flow | -16,023 | -10,708 | -3,532 | -12,804 | -8,800 |